Skip to main content
. 2019 Apr 16;11:3079–3097. doi: 10.2147/CMAR.S193325

Table 9.

Questions on guidelines and recommendations II by general practitioners and urologists

Question Categories GPs Urologists
Mean (SD) Median 1st Quartile 3rd Quartile n Mean (SD) Median 1st Quartile 3rd Quartile n
If yes (you are aware of the guidelines and study recommendations/results), do you consider them in your daily practice regarding PSA testing? DEGAM recommendations 56.6 (31.4) 57.0 40.0 83.8 40 11.8 (15.6) 5.0 2.0 26.0 11
German S3 guideline 38.7 (28.9) 37.5 13.3 57.0 40 94.9 (7.7) 96.0 91.8 101.0 14
EAU guidelines 20.3 (22.5) 7.0 2.0 46.0 23 64.8 (35.9) 73.5 26.5 101.0 14
AUA recommendations 12.3 (16.0) 5.0 1.0 20.0 13 26.8 (28.5) 20.5 1.8 47.5 14
NCCNguidelines 12.6 (17.7) 4.5 1.0 19.8 10 13.1 (12.3) 6.0 1.0 27.0 11
ACS guidelines 14.5 (17.7) 6.5 5.0 18.5 14 21.3 (25.8) 19.0 1.8 27.8 10
USPSTF recommendations 14.8 (18.8) 8.5 1.8 21.5 10 13.4 (12.6) 12.5 1.0 24.3 10
ERSPC 14.7 (17.4) 6.0 1.0 29.0 19 42.8 (35.0) 34.5 12.8 73.8 12
PLCO 14.9 (19.1) 1.0 1.0 37.0 11 10.8 (20.5) 2.0 1.0 11.5 9

Abbreviations: ACS, American Cancer Society; AUA, American Urological Association; EAU, European Association of Urology; DEGAM, German College of General Practice and Family Medicine; ERSPC, European Randomized Study of Screening for Prostate Cancer; GPs, general practitioners; PLCO, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; PSA, prostate-specific antigen; NCCN, National Comprehensive Cancer Network; USPSTF, United States Preventive Services Task Force.